US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 1.080
  • -0.030-2.70%
Close Jun 7 16:00 ET
  • 1.070
  • -0.010-0.93%
Post 19:07 ET
44.87MMarket Cap-552P/E (TTM)

Carisma Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
4.75%3.4M
51.71%14.92M
14.96%4.29M
48.45%3.83M
31.71%3.56M
294.53%3.24M
9.83M
3.73M
2.58M
2.7M
Operating revenue
4.75%3.4M
51.71%14.92M
14.96%4.29M
48.45%3.83M
31.71%3.56M
294.53%3.24M
--9.83M
--3.73M
--2.58M
--2.7M
Cost of revenue
Gross profit
Operating expense
-12.62%22.91M
57.05%103.65M
40.34%26.74M
35.40%26.17M
47.42%24.53M
138.80%26.22M
61.78%66M
19.05M
19.33M
16.64M
Selling and administrative expenses
-43.13%5.45M
214.83%29.53M
654.27%7.32M
75.50%6.62M
147.81%6.01M
333.02%9.57M
46.37%9.38M
--971K
--3.77M
--2.42M
-General and administrative expense
-43.13%5.45M
214.83%29.53M
654.27%7.32M
75.50%6.62M
147.81%6.01M
333.02%9.57M
46.37%9.38M
--971K
--3.77M
--2.42M
Research and development costs
4.93%17.46M
30.92%74.13M
7.37%19.42M
25.67%19.55M
30.30%18.52M
89.81%16.64M
64.65%56.62M
--18.08M
--15.56M
--14.21M
Operating profit
15.07%-19.51M
-57.99%-88.73M
-46.52%-22.45M
-33.39%-22.34M
-50.47%-20.97M
-126.19%-22.97M
-37.67%-56.16M
-15.32M
-16.75M
-13.93M
Net non-operating interest income expense
136.02%532K
161.56%1.94M
249.37%1.3M
203.63%941K
252.66%1.18M
-146.58%-1.48M
-31,550.00%-3.15M
-867K
-908K
-771K
Non-operating interest income
----
--1.94M
----
----
----
----
----
----
----
----
Non-operating interest expense
----
----
----
----
----
----
--3.15M
----
----
----
Total other finance cost
-136.02%-532K
----
----
-203.63%-941K
-252.66%-1.18M
146.58%1.48M
----
----
--908K
--771K
Other net income (expense)
95.62%-84K
0
84.92%-84K
-1.92M
-550K
-668K
-144K
Gain on sale of security
----
95.62%-84K
--0
----
----
84.92%-84K
---1.92M
---550K
---668K
---144K
Income before tax
22.64%-18.98M
-41.90%-86.88M
-26.38%-21.16M
-16.78%-21.4M
-33.27%-19.79M
-116.88%-24.53M
-50.12%-61.23M
-16.74M
-18.33M
-14.85M
Income tax
0
0
88K
109K
0
0
Net income
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
-16.74M
-18.33M
-14.85M
Net income continuous Operations
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
---16.74M
---18.33M
---14.85M
Minority interest income
Net income attributable to the parent company
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
-16.74M
-18.33M
-14.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
-16.74M
-18.33M
-14.85M
Basic earnings per share
76.17%-0.46
-70.29%-2.59
-15.43%-0.48
-16.41%-0.53
-32.84%-0.49
-586.81%-1.93
-50.12%-1.521
-0.4158
-0.4553
-0.3689
Diluted earnings per share
76.17%-0.46
-70.29%-2.59
-15.43%-0.48
-16.41%-0.53
-32.84%-0.49
-586.81%-1.93
-50.12%-1.521
-0.4158
-0.4553
-0.3689
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 4.75%3.4M51.71%14.92M14.96%4.29M48.45%3.83M31.71%3.56M294.53%3.24M9.83M3.73M2.58M2.7M
Operating revenue 4.75%3.4M51.71%14.92M14.96%4.29M48.45%3.83M31.71%3.56M294.53%3.24M--9.83M--3.73M--2.58M--2.7M
Cost of revenue
Gross profit
Operating expense -12.62%22.91M57.05%103.65M40.34%26.74M35.40%26.17M47.42%24.53M138.80%26.22M61.78%66M19.05M19.33M16.64M
Selling and administrative expenses -43.13%5.45M214.83%29.53M654.27%7.32M75.50%6.62M147.81%6.01M333.02%9.57M46.37%9.38M--971K--3.77M--2.42M
-General and administrative expense -43.13%5.45M214.83%29.53M654.27%7.32M75.50%6.62M147.81%6.01M333.02%9.57M46.37%9.38M--971K--3.77M--2.42M
Research and development costs 4.93%17.46M30.92%74.13M7.37%19.42M25.67%19.55M30.30%18.52M89.81%16.64M64.65%56.62M--18.08M--15.56M--14.21M
Operating profit 15.07%-19.51M-57.99%-88.73M-46.52%-22.45M-33.39%-22.34M-50.47%-20.97M-126.19%-22.97M-37.67%-56.16M-15.32M-16.75M-13.93M
Net non-operating interest income expense 136.02%532K161.56%1.94M249.37%1.3M203.63%941K252.66%1.18M-146.58%-1.48M-31,550.00%-3.15M-867K-908K-771K
Non-operating interest income ------1.94M--------------------------------
Non-operating interest expense --------------------------3.15M------------
Total other finance cost -136.02%-532K---------203.63%-941K-252.66%-1.18M146.58%1.48M----------908K--771K
Other net income (expense) 95.62%-84K084.92%-84K-1.92M-550K-668K-144K
Gain on sale of security ----95.62%-84K--0--------84.92%-84K---1.92M---550K---668K---144K
Income before tax 22.64%-18.98M-41.90%-86.88M-26.38%-21.16M-16.78%-21.4M-33.27%-19.79M-116.88%-24.53M-50.12%-61.23M-16.74M-18.33M-14.85M
Income tax 0088K109K00
Net income 22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M-16.74M-18.33M-14.85M
Net income continuous Operations 22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M---16.74M---18.33M---14.85M
Minority interest income
Net income attributable to the parent company 22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M-16.74M-18.33M-14.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M-16.74M-18.33M-14.85M
Basic earnings per share 76.17%-0.46-70.29%-2.59-15.43%-0.48-16.41%-0.53-32.84%-0.49-586.81%-1.93-50.12%-1.521-0.4158-0.4553-0.3689
Diluted earnings per share 76.17%-0.46-70.29%-2.59-15.43%-0.48-16.41%-0.53-32.84%-0.49-586.81%-1.93-50.12%-1.521-0.4158-0.4553-0.3689
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg